Fund overlap
Nippon India Pharma Fund vs SBI HEALTHCARE OPPORTUNITIES FUND
Fund A
Nippon India Pharma Fund
Nippon India Pharma Fund - Direct Plan - IDCW Option
Open Ended Schemes(Equity Schemes - Sectoral Fund) · Nippon India Mutual Fund
Fund B
SBI HEALTHCARE OPPORTUNITIES FUND
SBI HEALTHCARE OPPORTUNITIES FUND - Direct Plan - IDCW
Open Ended Schemes(Equity Scheme - Sectoral/ Thematic) · SBI Mutual Fund
Overlap
29.9%
- Shared holdings
- 17
- Holdings in A
- 38
- Holdings in B
- 37
Overlap measures how closely the two portfolios match, holding by holding and weight by weight, using each fund's latest disclosed holdings. 100% would mean the same holdings at the same weights.
Shared holdings
The 10 largest of 17 shared holdings, ordered by the smaller of the two weights.
| Holding | Nippon India Pharma Fund | SBI HEALTHCARE OPPORTUNITIES FUND |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 11.71% | 11.14% |
| Divi's Laboratories Limited | 7.10% | 7.91% |
| Apollo Hospitals Enterprise Limited | 4.89% | 4.45% |
| Cipla Limited | 6.01% | 4.40% |
| Max Healthcare Institute Limited | 2.70% | 3.80% |
| Sai Life Sciences Limited | 3.92% | 2.60% |
| Gland Pharma Limited | 2.53% | 2.96% |
| Ajanta Pharma Limited | 3.61% | 1.79% |
| Mankind Pharma Limited | 4.38% | 1.71% |
| Aurobindo Pharma Limited | 1.65% | 3.42% |
Data as of 30 Sept 2026
Method: weighted Jaccard
Weighted Jaccard adds up the smaller weight of every holding across both funds and divides by the sum of the larger weights.